Form 4 · Filed Jul 13, 2026, 08:41 PM UTC
BBIO/BridgeBio Pharma, Inc.
Ellis Andrea — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | M | other | 17,167 | $17 | $287,547 | 39,746 |
| Jul 9, 2026 | S | sell | 17,167 | $84 | $1,442,028 | 22,579 |
| Jul 9, 2026 | M | other | 17,167 | — | — | 17,167 |
Source: SEC EDGAR raw filing ↗ · Accession 0001470831-26-000709